SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-006062
Filing Date
2021-03-16
Accepted
2021-03-16 08:00:37
Documents
77
Period of Report
2021-01-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 580716
2 ex31-1.htm EX-31.1 18254
3 ex31-2.htm EX-31.2 18786
4 ex32-1.htm EX-32.1 6256
5 ex32-2.htm EX-32.2 6331
  Complete submission text file 0001493152-21-006062.txt   3421101

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE adxs-20200131.xml EX-101.INS 532369
7 XBRL SCHEMA FILE adxs-20200131.xsd EX-101.SCH 44521
8 XBRL CALCULATION FILE adxs-20200131_cal.xml EX-101.CAL 71727
9 XBRL DEFINITION FILE adxs-20200131_def.xml EX-101.DEF 135392
10 XBRL LABEL FILE adxs-20200131_lab.xml EX-101.LAB 315265
11 XBRL PRESENTATION FILE adxs-20200131_pre.xml EX-101.PRE 256707
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 21743671
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences